Figure 1From: Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the dayStudy design. Twelve participants discontinued prior to randomization; 4 participants discontinued during the crossover period; 2 participants discontinued after the crossover phase; 9 participants discontinued because of AEs; no participants discontinued because of lack of efficacy.Back to article page